Enanta Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

View All

Latest Posts

About This Stock More About This Stock
5 Top Performing Stocks Of The Best ETF Of 1H2018
Article By: Sweta Killa
Saturday, June 30, 2018 6:20 PM EDT
PowerShares S&P SmallCap Healthcare Fund PSCH​ topped the list of best performing equity ETFs of the first half of 2018, with impressive returns of about 30.6%. The rally was mainly driven by tax reform, rising M&A and positive regulatory backdrop.
In this article: PSCH, TCMD, RGNX, ENTA, TRHC, SRDX
Read
Enanta Pharmaceuticals - Chart Of The Day
Article By: Jim Van Meerten
Friday, January 26, 2018 4:33 PM EDT
Since the Trend Spotter signaled a buy on 12/13 the stock gained 44.83%.
In this article: ENTA
Read
4 Drug Stocks In Focus This World Hepatitis Day
Article By: Arpita Dutt
Friday, July 28, 2017 10:45 AM EDT
The HCV market will continue to face challenges as more treatments enter the market resulting in increased competition and additional pricing pressure. In fact, HCV drugs have faced immense scrutiny due to their high prices.
In this article: GILD, MRK, ABBV, ENTA
Read
AbbVie/Enanta Post Stellar Phase 3 Data But No One Is Cheering
Article By: Lorimer Wilson
Friday, April 21, 2017 2:54 AM EDT
AbbVie Inc. and its partner Enanta Pharmaceuticals, Inc. received exceedingly good news about new Phase III data but since these drugs first went into combo clinical trials, the market has peaked and begun a painful retreat.
In this article: ABBV, ENTA Also: MRK, GILD
Read
5 Biotech Stocks To Watch As Interest In NASH Increases
Article By: Arpita Dutt
Thursday, September 22, 2016 1:45 PM EDT
The market is suddenly abuzz about nonalcoholic steatohepatitis or NASH, a common but often “silent” liver disease. Several companies are working on developing treatments for NASH – the market could be worth billions of dollars.
In this article: ICPT, CNAT, GALT, ENTA, GLMD Also: AGN
Read
All Posts

Latest Tweets for $ENTA

No tweets yet!

PARTNER HEADLINES

$ENTA

Comments Status Updates
2 Hot Biotechs Set To Deliver Paydays To Investors In 2015
Paul McGee • 2/2/2015 12:32:09 AM

One the best overviews of $ENTA I've seen... specially interested in the super bug research which will produce "new news".

1 to 1 of 1 comments